Second Sight Medical Products Inc
EYESW · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13,124 | $13,022 | $13,020 | $12,085 |
| - Cash | $2,628 | $6,794 | $13,008 | $18,352 |
| + Debt | $18,293 | $18,616 | $18,940 | $19,313 |
| Enterprise Value | $28,789 | $24,844 | $18,952 | $13,046 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | – | 100% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | 50% |
| EBITDA | -$6,512 | -$7,462 | -$6,557 | -$19,272 |
| % Margin | – | – | – | 7,412,370.4% |
| Net Income | -$6,530 | -$7,144 | -$6,302 | -$20,479 |
| % Margin | – | – | – | 7,876,568.8% |
| EPS Diluted | -0.11 | -0.12 | -0.11 | -0.35 |
| % Growth | 8.3% | -9.1% | 68.6% | – |
| Operating Cash Flow | -$4,410 | -$8,028 | -$5,163 | -$19,765 |
| Capital Expenditures | -$818 | -$76 | -$5 | -$538 |
| Free Cash Flow | -$5,228 | -$8,104 | -$5,168 | -$20,303 |